Cargando…
The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis
Purinergic receptor signaling is increasingly recognized as an important regulator of inflammation. The P2X family purinergic receptors P2X5 and P2X7 have both been implicated in bone biology, and it has been suggested recently that P2X5 may be a significant regulator of inflammatory bone loss. Howe...
Autores principales: | Kim, Hyunsoo, Kajikawa, Tetsuhiro, Walsh, Matthew C., Takegahara, Noriko, Jeong, Yun Hee, Hajishengallis, George, Choi, Yongwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177510/ https://www.ncbi.nlm.nih.gov/pubmed/30103845 http://dx.doi.org/10.5483/BMBRep.2018.51.9.126 |
Ejemplares similares
-
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts
por: Kim, Hyunsoo, et al.
Publicado: (2017) -
IgSF11-mediated phosphorylation of pyruvate kinase M2 regulates osteoclast differentiation and prevents pathological bone loss
por: Kim, Hyunsoo, et al.
Publicado: (2023) -
Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation
por: Kim, Hyunsoo, et al.
Publicado: (2020) -
CD44 Can Compensate for IgSF11 Deficiency by Associating with the Scaffold Protein PSD-95 during Osteoclast Differentiation
por: Kim, Hyunsoo, et al.
Publicado: (2020) -
Protocadherin-7 Regulates Osteoclast Differentiation through Intracellular SET-Binding Domain-Mediated RhoA and Rac1 Activation
por: Kim, Hyunsoo, et al.
Publicado: (2021)